Gene · 29116
Papers1,569
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,569
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-coding RNAs and gastrointestinal cancers prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies. | Front Oncol | 2023 | 37546412 | PubTator, text mining | PubMed |
| Global gene expression analysis reveals a subtle effect of DEHP in human granulosa cell line HGrC1. | Reprod Toxicol | 2023 | 37536456 | PubTator, text mining | PubMed |
| Flindissone, a Limonoid Isolated from Trichilia prieuriana, Is an LXR Agonist. | J Nat Prod | 2023 | 37526502 | PubTator, text mining | PubMed |
| Kunjin Virus, Zika Virus, and Yellow Fever Virus Infections Have Distinct Effects on the Coding Transcriptome and Proteome of Brain-Derived U87 Cells. | Viruses | 2023 | 37515107 | PubTator, text mining | PubMed |
| Circulating microRNAs as diagnostic biomarkers for ischemic stroke: evidence from comprehensive analysis and real-world validation. | Int J Med Sci | 2023 | 37484808 | PubTator, text mining | PubMed |
| The effects of statin therapy on brain tumors, particularly glioma: a review. | Anticancer Drugs | 2023 | 37466094 | PubTator, text mining | PubMed |
| MiR-3653 blocks autophagy to inhibit epithelial-mesenchymal transition in breast cancer cells by targeting the autophagy-regulatory genes ATG12 and AMBRA1. | Chin Med J (Engl) | 2023 | 37464439 | PubTator, text mining | PubMed |
| Integrated analysis of single-cell and Bulk RNA sequencing reveals a malignancy-related signature in lung adenocarcinoma. | Front Oncol | 2023 | 37427142 | PubTator, text mining | PubMed |
| METTL5 serves as a diagnostic and prognostic biomarker in hepatocellular carcinoma by influencing the immune microenvironment. | Sci Rep | 2023 | 37400463 | PubTator, text mining | PubMed |
| Biological stability of DNA methylation measurements over varying intervals of time and in the presence of acute stress. | Epigenetics | 2023 | 37393564 | PubTator, text mining | PubMed |
| UBE2C expression is elevated in hepatoblastoma and correlates with inferior patient survival. | Front Genet | 2023 | 37377594 | PubTator, text mining | PubMed |
| miR-145 as a Potential Biomarker and Therapeutic Target in Patients with Non-Small Cell Lung Cancer. | Int J Mol Sci | 2023 | 37373169 | PubTator, text mining | PubMed |
| Exploring the Potential Role of Circulating microRNAs as Biomarkers for Predicting Clinical Response to Neoadjuvant Therapy in Breast Cancer. | Int J Mol Sci | 2023 | 37373139 | PubTator, text mining | PubMed |
| A Review of Progress on Targeting LDL Receptor-Dependent and -Independent Pathways for the Treatment of Hypercholesterolemia, a Major Risk Factor of ASCVD. | Cells | 2023 | 37371118 | PubTator, text mining | PubMed |
| Construction of a risk model and prediction of prognosis and immunotherapy based on cuproptosis-related LncRNAs in the urinary system pan-cancer. | Eur J Med Res | 2023 | 37370148 | PubTator, text mining | PubMed |
| Hematopoietic stem cells and betaherpesvirus latency. | Front Cell Infect Microbiol | 2023 | 37346032 | PubTator, text mining | PubMed |
| Liver X Receptor-Inducible Host E3 Ligase IDOL Targets a Human Cytomegalovirus Reactivation Determinant. | J Virol | 2023 | 37338407 | PubTator, text mining | PubMed |
| Differentially expressed miRNA profiles of serum-derived exosomes in patients with sudden sensorineural hearing loss. | Front Neurol | 2023 | 37332997 | PubTator, text mining | PubMed |
| Comparative and integrative analysis of transcriptomic and epigenomic-wide DNA methylation changes in African American prostate cancer. | Epigenetics | 2023 | 37279148 | PubTator, text mining | PubMed |
| Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq. | Front Immunol | 2023 | 37256127 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/29116/papers?page=6